Search results
Sonnet BioTherapeutics Provides Fiscal Year 2024 Second Quarter and Year-to-Date Business and...
Digital Journal· 13 hours ago...-1010 in Frontiers in Immunology demonstrating the safety and tolerability of the F H AB-derived Interleukin 12 in healthy volunteers Announced early safety data from the company's Phase 1b/2a clinical trial of SON-080 in patients with chemotherapy-induced peripheral neuropathy (CIPN) Received...
Exploring the latest trends in clinical trials: A glimpse into the future
Nutraingredients.com· 8 hours agoThis type of trial involves randomly assigning participants to two or more groups (an experimental group and a control group) and comparing the outcomes of the groups to determine the effectiveness ...
Ainos to Initiate Clinical Study of New Potential VELDONA-Based Animal Drug, Expanding VELDONA's...
Digital Journal· 13 hours agoClinical trials are expected to run for approximately ten months from May 24, 2024. SAN DIEGO, CA / ACCESSWIRE / May 15, 2024 / Ainos, Inc. (NASDAQ:AIMD, AIMDW) ("Ainos", or the "Company"), ...
New Wegovy clinical trial finds surprising benefits that go way beyond weight loss
KABC 7 Los Angeles· 5 hours agoFor the last few years, we've been hearing how semaglutide weight loss drugs can help with heart failure and heart attack. This week at the European Congress of Obesity, researchers released ...
Bolt Biotherapeutics Inc (BOLT) (Q1 2024) Earnings Call Transcript Highlights: Strategic Shifts ...
GuruFocus.com via Yahoo Finance· 7 hours agoProduct Focus: Prioritization of BDC 3042 and BDC 4182. Clinical Trials: Ongoing Phase one study of BDC 3042; planning clinical trial for BDC 4182 in 2025 ...
Ocugen completes second cohort dosing in Stargardt trial By Investing.com
Investing.com· 10 hours agoOcugen, Inc. (NASDAQ: NASDAQ:OCGN), a biotechnology company, announced today the completion of...
Earnings call: GeoVax reports progress on key vaccine trials By Investing.com
Investing.com· 11 hours agoGeoVax, a biotechnology company focusing on developing vaccines for cancer and infectious diseases,...
Just months after public offering, Absci heading for clinical trials with a biologic drug candidate
The Columbian· 1 day agoAfter raising nearly $90 million in its recent public offering, Vancouver-based Absci is advancing...
Recce Pharmaceuticals doses first participants in next cohort Phase I/II UTI/Urosepsis rapid...
Proactive Investors· 22 hours agoRecce Pharmaceuticals Ltd (ASX:RCE, OTC:RECEF) has dosed the first participants in the next cohort...
New Clinical Trial Finds Faster Approach for Starting Extended-Release Naltrexone to Treat Opioid...
Sierra Sun Times· 5 days agoNIH-supported clinical trial addresses important barrier to opioid use disorder treatment. May 11,...